ERDERA Clinical Trial Call 2026 - Pre-Announcement 

12/06/2026

- 1 July 2026 Call Opens
-6 July 2026 Information webinar
- 10 September 2026 Expression of Interest deadline
- 29 October 2026 Short proposal submission deadline

The European Rare Diseases Research Alliance (ERDERA) has announced its upcoming Clinical Trial Call 2026, which will support multinational, sponsor-led Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases.

An information webinar for potential applicants will take place on 6 July 2026, 15:00–17:00 CEST, providing guidance on the call scope, eligibility, application process and funding structure. Registration is required:

https://erdera.org/event/erdera-clinical-trial-call-2026-information-webinar/

Further information and registration for the webinar are available on the official website:

https://erdera.org/call/ctc2026

HMRIB researchers interested in applying can contact Júlia Vidal ([email protected]) and Chris George ([email protected]) at the Research Grants and Contracts Office.